FDA: LABA Use with ICS Does Not Increase Risk of Serious Outcomes
December 22nd 2017Officials with the FDA have concluded that treating patients with asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related side effects than treatment with ICS alone, prompting removal of a boxed warning about the potential effects.
FDA OKs New GLP-1 Receptor Agonist for Type 2 Diabetes
December 5th 2017The FDA has approved Novo Nordisk's glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Ozempic), indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, according to a company announcement.
ACIP Endorses Use of Herpes Zoster Vaccine
October 25th 2017In a narrow 8-7 vote, the Advisory Committee on Immunization Practices (ACIP) endorsed the use of the newly FDA approved zoster vaccine recombinant, adjuvanted (Shingrix, GlaxoSmithKline) over the established zoster vaccine live (Zostavax, Merck).
Opioid Overuse and Adverse Effects on the Rise in US Children
September 20th 2017Opioid-related problems, such as adverse reactions and opioid dependency, are increasing among children in the United States, according to 2 study abstracts presented at the recent American Academy of Pediatrics 2017 National Conference in Chicago.